Waltham, Mass.-based ImmunoGen (NASDAQ:IMGN) will lose its CFO in two weeks.

On Tuesday, ImmunoGen announced that Chief Financial Officer Gregory D. Perry intends to resign from the company "to pursue other interests," effective Sept. 13. At that time, Perry will be paid a "salary continuation benefit" equal to 12 months' salary. His salary is currently listed at $477,958, according to S&P Capital IQ.

Once Perry is gone, company Chief Executive Officer Daniel M. Junius will take over his duties as acting CFO, while simultaneously keeping the CEO job. The company is currently seeking a more permanent replacement for Perry.

Fool contributor Rich Smith has no position in any stocks mentioned. The Motley Fool recommends ImmunoGen. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.